1. Home
  2. SEE vs BLTE Comparison

SEE vs BLTE Comparison

Compare SEE & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sealed Air Corporation

SEE

Sealed Air Corporation

HOLD

Current Price

$42.15

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$171.33

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEE
BLTE
Founded
1960
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.5B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SEE
BLTE
Price
$42.15
$171.33
Analyst Decision
Buy
Strong Buy
Analyst Count
11
7
Target Price
$43.50
$198.00
AVG Volume (30 Days)
3.0M
148.5K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
1.90%
N/A
EPS Growth
89.50
N/A
EPS
3.43
N/A
Revenue
$5,359,800,000.00
N/A
Revenue This Year
$1.93
N/A
Revenue Next Year
$2.27
$492.11
P/E Ratio
$12.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.56
$53.60
52 Week High
$44.27
$200.00

Technical Indicators

Market Signals
Indicator
SEE
BLTE
Relative Strength Index (RSI) 65.73 55.03
Support Level $41.79 $167.80
Resistance Level $42.21 $174.78
Average True Range (ATR) 0.08 8.50
MACD 0.02 2.11
Stochastic Oscillator 100.00 71.15

Price Performance

Historical Comparison
SEE
BLTE

About SEE Sealed Air Corporation

Sealed Air Corp is a provider of packaging solutions that integrate sustainable, high-performance materials, automation, equipment, and services. The company designs, manufactures, and delivers packaging solutions that preserve food, protect goods, and automate packaging processes. It delivers its packaging solutions to an array of end markets including fresh proteins, foods, fluids and liquids, medical and life science, e-commerce retail, logistics and omnichannel fulfillment operations, and industrials. It has two reportable segments, Food and Protective. The company generates majority of its revenue from the food segment.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: